证券代码：301187 证券简称：欧圣电气 苏州欧圣电气股份有限公司 投资者关系活动记录表 编号：2025-002 投资者关系活动类别 特定对象调研 ☐ 分析师会议 ☐ 媒体采访 ☐ 业绩说明会 ☐ 新闻发布会 ☐ 路演活动 现场参观 ☐其他 参与单位名称 中信证券股份有限公司、中信建投证券股份有限公司、中 信证券资产管理有限公司、申万菱信基金管理有限公司、 平安养老保险股份有限公司、国海创新资本投资管理有限 公司、上海杉玺投资管理有限公司、深圳创富兆业金融管 理有限公司、山东国泰租赁有限公司、山东国惠基金管理 有限公司、东吴创新资本管理有限责任公司、上海宝弘景 资产管理有限公司 时间 2025年11月18日 10:00-12:00 地点 江苏省苏州市吴江区汾湖高新技术开发区来秀路888号公 司会议室 上市公司接待人员姓名 董事会秘书 罗刚 投资者关系活动主要 内容介绍 一、投资者交流主要问题： 1、公司的三季报数据利润有较大的下滑是什么原 因，明年能重新回到高速增长的轨道吗？ 今年一季度公司业绩维持高速增长，但自二季度起受 中美关税战影响，公司业务受到较大冲击。为提升竞争力 2025 年第三季度，受马来西亚 ...

丨证券研究报告丨 [Table_scodeMsg1] 港股研究丨公司点评丨裕元集团（00551.HK） [Table_Title] 制造产能爬坡形成拖累，关店及客流影响零售承 压 报告要点 [Table_Summary] 裕元集团 2025 年前三季度实现营收 60.2 亿美元，同比-1.0%，归母净利润 2.8 亿美元，同比- 16.0%。其中制造业务实现营收 42.3 亿美元，同比+2.3%，归母净利润 2.6 亿美元，同比-12.6%； 宝胜实现营收 17.9 亿美元，同比-7.9%，归母净利润 0.2 亿美元，同比-50.3%。 裕元集团 2025Q3 实现营收 19.6 亿美元，同比-5.0%，归母净利润 1.1 亿美元，同比-27.0%。 其中制造业务实现营收 14.3 亿美元，同比-4.5%，归母净利润 1.1 亿美元，同比-25.7%；宝胜 实现营收 5.2 亿美元，同比-6.3%，归母净利润-218.7 万美元，同比转亏。 分析师及联系人 [Table_Author] 于旭辉 魏杏梓 SAC：S0490518020002 SAC：S0490524020003 SFC：BUU942 请阅读最后 ...

Core Viewpoint - Jinfu Technology's stock price has surged nearly 100% since the beginning of the year, despite a decline in revenue and net profit in the first three quarters of the year, indicating market optimism about its long-term growth potential [1][2]. Financial Performance - For the first three quarters of the year, Jinfu Technology reported revenue of approximately 662 million yuan, a year-on-year decrease of 9.12% [1][2]. - The company achieved a net profit attributable to shareholders of about 93.44 million yuan, down 19.45% year-on-year [1][2]. - The decline in performance is attributed to new production bases entering a ramp-up phase, leading to increased depreciation and amortization costs, as well as temporary production disruptions [1][2]. Market Position and Client Base - Jinfu Technology primarily serves major beverage companies such as JingTian, Coca-Cola, and Yanjing Group, with a high customer concentration [2][3]. - The company ranks fifth in revenue among eight industry peers, with its revenue of 662 million yuan, while the top company, Zijiang Enterprise, reported 7.82 billion yuan [3][4]. - In terms of net profit, Jinfu Technology ranks third, with a net profit of 93.44 million yuan, compared to Zijiang Enterprise's 966 million yuan [3]. Industry Trends - The demand for plastic bottle caps is driven by the significant growth in global bottled water, juice, and functional beverage consumption [3]. - The Chinese bottled water market has surpassed 100 billion yuan, leading to increased demand for standard 28mm bottle caps [3]. - There is a growing trend towards high-end, lightweight, and biodegradable caps due to the rising health consciousness among consumers [3]. Strategic Initiatives - Jinfu Technology is transitioning from plastic packaging to metal packaging, with plans to invest in new metal cap production lines [3][4]. - The company has reduced its investment commitments for several projects, including the plastic cap production base expansion, and is reallocating funds towards the metal cap project and the acquisition of Xiangzhao Technology [4][5]. - The acquisition of Xiangzhao Technology aims to enhance production capacity for new metal pull-ring caps, securing orders from clients like Yanjing Beer [5].

Core Viewpoint - Jinfu Technology's stock price has surged nearly 100% since January 1, despite poor financial performance in the first three quarters of 2025, indicating market optimism about its long-term growth potential and strategic partnerships with major clients like JingTian and Coca-Cola [1][5][6]. Financial Performance - For the first three quarters of 2025, Jinfu Technology reported revenue of approximately 662 million yuan, a year-on-year decline of 9.12%, and a net profit of about 93.44 million yuan, down 19.45% year-on-year [5]. - The decline in performance is attributed to new production bases entering a ramp-up phase, leading to increased depreciation and amortization costs, as well as temporary production disruptions [5]. Market Position and Client Base - Jinfu Technology primarily serves major beverage companies, with its top five clients contributing significantly to its revenue, although the proportion of sales to these clients has decreased [6]. - The company ranks fifth in revenue among eight industry peers, with its revenue of 662 million yuan, while the top competitor, Zijiang Enterprise, reported 7.82 billion yuan [7]. Strategic Initiatives - Jinfu Technology is transitioning from plastic packaging to metal packaging, with plans to invest in new projects and acquire 100% of Xiangzhao Technology to enhance its production capacity for new types of pull-ring caps [8]. - The company has reduced its investment commitments for several projects, indicating a strategic shift in focus towards metal cap production [8]. Industry Trends - The demand for plastic bottle caps is increasing due to the growth in bottled water and beverage consumption, with the bottled water market in China exceeding 100 billion yuan [7]. - The industry is experiencing a shift towards high-end products, driven by health-conscious consumer trends and the demand for lightweight and biodegradable caps [7].

Core Viewpoint - The company is actively enhancing its domestic production lines and capacity, indicating a positive outlook for future performance as it navigates through a phase of operational improvement and market demand adaptation [2]. Group 1: Company Operations - The company has been focusing on the continuous construction and operation of its domestic production lines [2]. - The Beijing FAB3 production line is currently in a capacity ramp-up phase, which involves a necessary process of product development, validation, and mass production [2]. - The company plans to expand its process development and wafer manufacturing categories based on market demand, aiming to continuously improve yield rates [2]. Group 2: Market Outlook - The company suggests that its ongoing efforts in production and operational improvements may lead to a turnaround in its performance, aligning with investor inquiries about future prospects [2].

Core Viewpoint - The company is experiencing a recovery in traditional business growth, with emerging businesses gradually ramping up, leading to improved profitability quarter by quarter [1] Financial Performance - For Q1-Q3 2025, revenue reached 2.544 billion yuan, a year-on-year increase of 19.7%, with a net profit attributable to shareholders of 79.92 million yuan, marking a turnaround from losses [2] - In Q3 alone, revenue was 923 million yuan, up 19.4% year-on-year, and net profit was 52.86 million yuan, significantly improving from losses, with a quarter-on-quarter growth of 68.7% [2] - The gross margin for Q1-Q3 2025 was 28.86%, an increase of 5.6 percentage points year-on-year, while Q3 gross margin was 31.02%, stable year-on-year and up 2.1 percentage points quarter-on-quarter [2] Business Segments - Revenue from small molecule APIs for Q1-Q3 2025 was 2.350 billion yuan, a year-on-year increase of 19.4%, while emerging business revenue was 190 million yuan, up 23.4% [3] - The small molecule formulation CDMO segment generated 101 million yuan, remaining flat year-on-year, while CGT CDMO revenue was 43 million yuan, up 7.1% [3] - New molecular businesses, including peptides, oligonucleotides, and ADCs, saw revenue of 46 million yuan, a substantial increase of 254.8% year-on-year [3] Market Performance - Overseas market revenue for Q1-Q3 2025 was 1.805 billion yuan, a year-on-year increase of 17%, while domestic market revenue was 739 million yuan, up 21% [3] Profitability Trends - The gross margin for the overseas market was approximately 40%, an increase of 5 percentage points year-on-year, driven by high-value commercial projects [4] - The domestic market gross margin was around 1%, improving from -3% in H1 2025; excluding emerging business impacts, the domestic gross margin was about 18% [4] - Overall gross margin for the company was approximately 35%, showing a trend of improvement [4] Emerging Business Impact - The new business segments negatively impacted the net profit attributable to shareholders by approximately 164 million yuan, with a total reduction in losses of about 17.5 million yuan [4] - The small molecule formulation, gene cell therapy, and new molecular businesses contributed to the net profit reductions of 67.69 million yuan, 38.67 million yuan, and 57.25 million yuan, respectively [4] Catalysts - There is an unexpected growth in orders and terminal demand for new businesses, indicating positive market dynamics [5]

证券日报网讯崇达技术（002815）11月7日在互动平台回答投资者提问时表示，公司近期折旧费用较 高，主要系珠海二厂、三厂及总部大厦陆续转固所致。新工厂投产初期，产能正处于快速爬坡阶段，而 营收贡献尚未完全释放。公司正通过加速高端产能释放(如服务器用高多层板)、优化订单结构提升高附 加值产品占比(目前高端板占比已超60%)等一系列措施，致力于提升营收规模及生产效率，以改善此阶 段性状况。 ...

Core Viewpoint - Huanhong Company reported a significant drop in net profit for Q3 despite achieving record sales revenue, leading to a notable decline in stock price [1][2] Financial Performance - Q3 revenue reached 45.66 billion yuan, a year-on-year increase of 21.10% [1] - Net profit attributable to shareholders was 1.77 billion yuan, a decrease of 43.47% year-on-year [1] - For the first three quarters, total revenue was 125.83 billion yuan, up 19.82% year-on-year, while net profit dropped 56.52% to 2.51 billion yuan [1] Cash Flow - Net cash flow from operating activities increased by 129.58% year-on-year, attributed to normal business operations rather than changes in accounts receivable or prepayments [1] Strategic Developments - The new chairman, Bai Peng, highlighted that Q3 sales revenue reached a historical high of 6.352 billion USD, with a gross margin of 13.5%, exceeding guidance expectations [2] - The company is actively pursuing an acquisition of Shanghai Huali Microelectronics, which is expected to enhance production capacity and improve profitability [2] Business Overview - Huanhong Company specializes in developing and applying embedded/non-volatile memory, power devices, analog and power management, and logic and RF technologies, providing wafer manufacturing services [2]

Investment Rating - The report maintains a "Buy-B" rating for the company [2][6] Core Views - The company's profitability has improved on a quarter-on-quarter basis, with overseas factory capacity ramping up contributing to incremental growth [2][4] - In Q3 2025, the company achieved total revenue of 10 billion yuan, representing a year-on-year increase of 18.0% and a quarter-on-quarter increase of 9.0% [3][4] - The company's tire sales reached 21.3 million units in Q3 2025, with year-on-year growth of 10.2% and quarter-on-quarter growth of 7.7% [4] Financial Performance - The company's gross profit margin and net profit margin in Q3 2025 were 25.09% and 10.72%, respectively, reflecting an increase of 0.7 and 1.8 percentage points quarter-on-quarter [4] - The average price of self-produced tires increased by 7.25% year-on-year, while the comprehensive procurement prices of key raw materials decreased by 8.30% year-on-year [4] - The company expects net profits for 2025, 2026, and 2027 to be 4.1 billion, 4.9 billion, and 5.5 billion yuan, respectively, corresponding to P/E ratios of 13, 11, and 9 times [6][8] Market Position and Strategy - The company has established tire production bases in various locations, including China and overseas in Vietnam, Cambodia, Mexico, and Indonesia, enhancing supply chain resilience [5] - The ramp-up of production capacity in Mexico and Indonesia is ongoing, with the first tires produced in May and August 2025, respectively [5]

Core Viewpoint - The company has fully commenced production at its Shanghai factory in Q3 2025, with a focus on meeting the increasing demand for harmonic reducers, which are currently in short supply in the market [1] Group 1: Production and Capacity - The company’s harmonic reducer production capacity is gradually ramping up [1] - The company has secured orders in multiple sectors and is committed to ensuring the delivery of these orders [1] Group 2: Market Demand - There is a strong market demand for the company’s harmonic reducer products, leading to a supply shortage [1]